MCK

MKT CAP:$102B

McKesson Corporation

Market Cap

$102B

Healthcare·Medical - Distribution·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$821.22-$2.22 (-0.27%)

Apr 24, 2026

Company Details

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The...

CEO

Brian S. Tyler

IPO Date

Nov 10, 1994

Website

www.mckesson.com

Key Metrics TTM

Revenue

$264.1B

— YoY

Net Income

-$273M

EPS (Diluted)

$0.49

Free Cash Flow

$2.2B

Revenue / Share

$2,104.22

Gross Margin

4.4%

Operating Margin

1.2%

Net Margin

-0.1%

FCF Margin

0.8%

P/S

0.4x

P/E

—

Earnings Reports

Q2 2026

May 7, 2026

PENDING

Q1 2026

Aug 6, 2025

$97.8BEPS $6.25

Q2 2020

Oct 30, 2019

$57.6B+8.6%EPS -$3.99

Q4 2019

May 15, 2019

$52.4BEPS -$4.17

Q3 2019

Jan 31, 2019

$56.2BEPS $2.40

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 19	$53.1B	$2.7B	$771M
Q3 19	$56.2B	$2.7B	$710M
Q4 19	$52.4B	$2.9B	$883M
Q2 20	$57.6B	$2.7B	$671M
Q1 26	$97.8B	$3.3B	$1.0B

Valuation

Quarter	P/S	P/E
Q2 19	—	—
Q3 19	—	—
Q4 19	—	—
Q2 20	0.1x	—
Q1 26	0.3x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 19	$1.4B	$1.3B
Q3 19	-$177M	-$334M
Q4 19	$3.9B	$3.7B
Q2 20	-$108M	-$181M
Q1 26	-$918M	-$1.0B

Capital Expenditures

Quarter	CapEx
Q2 19	$103M
Q3 19	$157M
Q4 19	$152M
Q2 20	$73M
Q1 26	$111M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 26	+84.3%	+85.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 19	$0	0.0%
Q3 19	$0	0.0%
Q4 19	$0	0.0%
Q2 20	$0	0.0%
Q1 26	$0	0.0%

OpEx Breakdown

Quarter	S&M	SG&A
Q2 19	—	$1.9B
Q3 19	—	$2.0B
Q4 19	—	$2.0B
Q2 20	—	$2.1B
Q1 26	$2.2B	—

Revenue Segments

Quarter	International Segment	Medical-Surgical Solutions Segment	Prescription Technology Solutions	U.S. Pharmaceutical Segment
Q1 26	$3.7B	$2.7B	$1.4B	$90.0B

Revenue by Geography

Quarter	International Segment	United States
Q2 19	$9.3B	$43.8B
Q3 19	$9.7B	$46.5B
Q4 19	$9.3B	$43.1B
Q2 20	$9.3B	$48.3B

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$3.5B	$0	$3.5B
Q1 23	$2.2B	$0	$2.2B
Q2 23	$2.9B	$0	$2.9B
Q3 23	$2.8B	$0	$2.8B
Q4 23	$4.7B	$0	$4.7B
Q1 24	$2.6B	$0	$2.6B
Q2 24	$2.5B	$0	$2.5B
Q3 24	$2.0B	$0	$2.0B
Q4 24	$4.6B	$0	$4.6B
Q1 25	$2.3B	$0	$2.3B
Q2 25	$2.5B	$0	$2.5B
Q3 25	$1.1B	$0	$1.1B
Q4 25	$5.7B	$0	$5.7B
Q1 26	$2.4B	$0	$2.4B
Q2 26	$4.1B	$0	$4.1B
Q3 26	$3.0B	$0	$3.0B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 19	199M	—	—
Q3 19	195M	-2.0%	—
Q4 19	191M	-2.1%	—
Q2 20	183M	-4.2%	—
Q1 26	126M	-31.4%	-36.9%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 19	$680.4K	78K
Q3 19	$720.6K	78K
Q4 19	$655.4K	80K
Q2 20	$720.2K	80K
Q1 26	$2M	45K

Revenue / Employee